Last reviewed · How we verify

NCT05723523: CI Wizard

A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment

Completed NA Last updated 4 November 2025
What this trial tests

NA trial testing CI-CDS in Dementia in 3,230 participants. Completed in 30 September 2025.

Timeline
23 August 2023
Primary endpoint
31 August 2025
30 September 2025

Quick facts

Lead sponsorHealthPartners Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment3,230
Start date23 August 2023
Primary completion31 August 2025
Estimated completion30 September 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

HealthPartners Institute

Who can join

65 and older, any sex, with Dementia or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most experts advocate for early detection of cognitive impairment (CI) so that patients and caregivers can be prepared for making difficult decisions and to improve quality of life, but studies show that screening alone isn't sufficient to change clinician actions related to early detection. Using predictive modelling developed with machine learning methods and sophisticated clinical decision support (CDS) tools, it is possible to identify patients at elevated risk for CI and make it much easier for primary care to engage and support patients and caregivers in meaningful care planning. The goal of this study is to implement and evaluate a low-cost, highly scalable CI-CDS system integrated within the electronic health record that has high potential to improve early CI detection and care and translate massive public and private sector investments in health informatics into tangible health benefits for large numbers of people.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Confidence in diagnosing and managing care for cognitive impairment in primary care: a survey comparing barriers by primary care clinician type.
    JaKa MM, Rossom RC, Borson S, O'Connor PJ, et al · · 2024 · cited 6× · PMID 39221923 · DOI 10.1093/fampra/cmae043
  2. Exposure to clinical decision support and training increases primary care clinician confidence in managing cognitive impairment care but not confidence to diagnose.
    JaKa MM, Rossom RC, Crouse B, Crain AL, et al · · 2025 · PMID 41225324 · DOI 10.1186/s12875-025-03053-z
  3. Design and protocol of a pragmatic clinical trial to improve cognitive impairment detection in primary care.
    Crouse B, Rossom RC, Crain AL, O'Connor PJ, et al · · 2025 · PMID 40953636 · DOI 10.1016/j.cct.2025.108080

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other HealthPartners Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05723523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing